References
- 1. Giannetti L, Dello Diago AM, Spinas E. Oral Lichen planus.J BiolRegulHomeost Agents. 2018 Mar–Apr; 32(2): 391–395.
- 2. Rock A, Wilkinson DS, Ebling FJ. Lichen planus and lichenoid eruptions. In: Textbook of dermatology,1972; 2: 1933–64.
- 3. Shklar G, Brackett CA. Common oral mucosal diseases. Med Times. 1981 Jun; 109(6): 33–40.
- 4. Warin RP, Crabb HS, Darling AI. Lichen planus of the mouth. Br Med J. 1958 Apr 26; 1(5077): 983–4.10.1136/bmj.1.5077.983
- 5. Regezi JA, Ellis CN, Stewart JC, Giustina TA.Histologic changes associated with the topical use of isotretinoin on oral lichen planus. Oral Surg Oral Med Oral Pathol. 1986 May; 61(5): 479–8410.1016/0030-4220(86)90391-9
- 6. Shklar G, Flynn E, Szabo G. Basement membrane alterations in oral lichen planus. J Invest Dermatol. 1978 Jan; 70(1): 45–50. No abstract available.10.1111/1523-1747.ep12543477
- 7. Powell ML, Ehrlich A, Belsito DV.Lichenoid drug eruption to salsalate. J Am Acad Dermatol. 2001 Oct; 45(4): 616–9.10.1067/mjd.2001.114593
- 8. Dogan S, Kılınç E, Özaygen GE, Atakan N, Gököz Ö, Evans SE.Childhood–Onset Keratosis Lichenoides Chronica Accompanied by Severe Hair Loss. Skinmed. 2017 Jun 1; 15(3): 211–213. E Collection 2017.
- 9. Bécherel PA, Bussel A, Chosidow O, Rabian C, Piette JC, Francès C.Extracorporeal photochemotherapy for chronic erosive lichen planus.Lancet. 1998 Mar 14; 351(9105): 805.10.1016/S0140-6736(05)78932-7
- 10. Guyot AD, Farhi D, Ingen–Housz–Oro S, Bussel A, Parquet N, Rabian C, Bachelez H, FrancèsC. Treatment of refractory erosive oral lichen planus with extracorporeal photochemotherapy: 12 cases.Br J Dermatol. 2007 Mar; 156(3): 553–6.10.1111/j.1365-2133.2006.07647.x
- 11. Sodaify M, Vollum DI.Familial lichen planus.A case report.Br J Dermatol. 1978 May; 98(5): 579–8110.1111/j.1365-2133.1978.tb01946.x
- 12. Lowe NJ, Cudworth AG, Woodrow JC. HL–A antigens in lichen planus. Br J Dermatol. 1976 Aug; 95(2): 169–71.10.1111/j.1365-2133.1976.tb00821.x
- 13. Поповска М. Имунолошки аспекти на орал-ниот лихен планус. Докторска дисертација, Стоматолошки факултет. Скопје, 2000.
- 14. Simon JC, Dietrich A, Mielke V, Wuttig C, Vanscheidt W, Linsley PS, Schöpf E, Sterry W. Expression of the B7/BB1 activation antigen and its ligand CD28 in T–cell–mediated skin diseases. J Invest Dermatol. 1994 Oct; 103(4): 539–43.10.1111/1523-1747.ep12395743
- 15. Regezi JA, Stewart JC, Lloyd RV, Headington JT.Immunohistochemical staining of Langerhans cells and macrophages in oral lichen planus. Oral Surg. Oral Med Oral Pathol. 1985 Oct; 60(4): 396–402.10.1016/0030-4220(85)90262-2
- 16. Regezi JA, Deegan MJ, Hayward JR.Lichen planus: immunologic and morphologic identification of the submucosal infiltrate.Oral Surg Oral Med Oral Pathol. 1978 Jul; 46(1): 44–52.10.1016/0030-4220(78)90436-X
- 17. Powell FC, Rogers RS, Dickson ER, Moore SB. An association between HLA DRI and lichen planus. Br J Dermatol. 1986 Apr; 114(4): 473–8.10.1111/j.1365-2133.1986.tb02852.x
- 18. Femiano F, De Crescenzo I, Battista C, Busciolano M. [HLA (Human Leukocyte Antigens) and oral immunological diseases]. Minerva Stomatol. 2001 Jan–Feb; 50(1–2): 21–30.
- 19. Malmström M, Fyhrquist F, Kosunen TU, Tasanen A. Immunological features of patients with chronic sclerosing osteomyelitis of the mandible. Int J Oral Surg. 1983 Feb; 12(1): 6–13.10.1016/S0300-9785(83)80074-X
- 20. Copeman PW, Tan RS, Timlin D, Samman PD. Familial lichen planus. Another disease or a distinct people? Br J Dermatol. 1978 May; 98(5): 573–7.10.1111/j.1365-2133.1978.tb01945.x656330
- 21. Hedberg NM, Hunter N. The expression of HLA–DR on keratinocytes in oral lichen planus. J Oral Pathol. 1987 Jan; 16(1): 31–5.10.1111/j.1600-0714.1987.tb00673.x2435876
- 22. Watanabe T, Ohishi M, Tanaka K, Sato H. Analysis of HLA antigens in Japanese with oral lichen planus. J Oral Pathol. 1986 Nov; 15(10): 529–33.10.1111/j.1600-0714.1986.tb00571.x3104559
- 23. Sun A, Wu YC, Wang JT, Liu BY, Chiang CP. Association of HLA–te22 antigen with anti–nuclear antibodies in Chinese patients with erosive oral lichen planus. Proc Natl Sci Counc Repub China B. 2000 Apr; 24(2): 63–9.
- 24. Поповска М. Лихен планус клинички манифестации и неговата имуногенетска асоцираност со антигените од ХЛА–системот. Магистерски труд, 1991, Стомаолошки факултет, Скопје.
- 25. Bombeccari GP, Guzzi G, Tettamanti M, et al. Oral lichen planus and malignant transformation: a longitudinal cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 112: 328–334.[PubMed]10.1016/j.tripleo.2011.04.00921782485
- 26. Al–Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103: S25.e1–S25.e12. [PubMed]10.1016/j.tripleo.2006.11.00117261375
- 27. Joanne Soo, BS, George Kokosis, Michael Ogilvie, Xiaoyin Sara Jiang, David B. Powers, Daniel J. Rocke JD, Detlev Erdmann, A Rare Case of Malignant Transformation of Oral Lichen Planus of the Mandible. Plast Reconstr Surg Glob Open. 2016 Dec; 4(12): e1070.10.1097/GOX.0000000000001070522263728293492
- 28. Koberg W, Schettler D, Selle G. [On the problem of the development of a carcinoma as a sequel of lichen ruber planus of the oral mucous membrane]. Munch Med Wochenschr. 1965; 107: 463–466.[PubMed]
- 29. Bermejo–Fenoll A, Sanchez–Siles M, López–Jornet P, et al. Premalignant nature of oral lichen planus. A retrospective study of 550 oral lichen planus patients from south–eastern Spain. Oral Oncol. 2009; 45: e54–e56. [PubMed]10.1016/j.oraloncology.2009.01.00919362039
- 30. Taghavi Zenouz A, Mehdipour M, Attaran R, et al. Squamous cell carcinoma arising from an oral lichenoid lesion: a case report. J Dent Res Dent Clin Dent Prospects. 2012; 6: 29–32. [PMC free article][PubMed]
- 31. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Critical Reviews in Oral Biology and Medicine. 2002; 13(4): 350–365. [PubMed]10.1177/15441113020130040512191961
- 32. Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clinics in Dermatology. 2010; 28(1): 100–108. [PubMed]10.1016/j.clindermatol.2009.03.00420082959
- 33. Lodi G, Scully C, Carrozzo M, et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2005; 100(1): 40–51. [PubMed]10.1016/j.tripleo.2004.06.07715953916
- 34. Gonzalez–Moles MA, Scully C, Gil–Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Diseases. 2008; 14(3): 229–243. [PubMed]10.1111/j.1601-0825.2008.01441.x18298420
- 35. Ergun S, Troşala ŞC, Warnakulasuriya S, et al. Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus. Journal of Oral Pathology and Medicine. 2011; 40(4): 286–293. [PubMed]10.1111/j.1600-0714.2010.00955.x21039889
- 36. Meek DW. The p53 response to DNA damage. DNA Repair. 2004; 3(8–9): 1049–1056. [PubMed]10.1016/j.dnarep.2004.03.02715279792
- 37. Safadi RA, Jaber SZA, Hammad HM, Hamasha AAH. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study. Archives of Oral Biology. 2010; 55(6): 454–461.10.1016/j.archoralbio.2010.03.01920427035
- 38. Sousa FA, Paradella TC, Carvalho YR, Rosa LE. Immunohistochemical expression of PCNA, p53, bax and bcl–2 in oral lichen planus and epithelial dysplasia. Journal of Oral Science. 2009; 51(1): 117–121.[PubMed]10.2334/josnusd.51.11719325208
- 39. Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, Rosin MP. Molecular analysis of oral lichen planus. Am J Pathol. 1997 Aug; 151(2): 323–327.
- 40. Zhou XJ, Sugerman PB, Savage NW, Walsh LJ. Matrix metalloproteinases and their inhibitors in oral lichen planus. Journal of Cutaneous Pathology. 2001; 28(2): 72–82. [PubMed]10.1034/j.1600-0560.2001.280203.x11168755
- 41. Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F. A comparison of the pro–inflammatory, NF–κB–dependent cytokines: TNF–alpha, IL–1–alpha, IL–6, and IL–8 in different oral fluids from oral lichen planus patients. Clinical Immunology. 2005; 114(3): 278–283. [PubMed]10.1016/j.clim.2004.12.00315721838
- 42. Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F. The feasibility of monitoring NF–κB associated cytokines: TNF–α, IL–1α, IL–6, and IL–8 in whole saliva for the malignant transformation of oral lichen planus. Molecular Carcino-genesis. 2005; 44(2): 77–82. [PubMed]10.1002/mc.20113
- 43. Canavan C, Abrams KR, Mayberry J. Meta–analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Alimentary Pharmacology and Therapeutics. 2006; 23(8): 1097–1104. [PubMed]10.1111/j.1365-2036.2006.02854.x
- 44. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population–based study. Cancer. 2001; 91(4): 854–862. [PubMed]10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z
- 45. Watanabe T, Ohishi M, Tanaka K, Sato H. Analysis of HLA antigens in Japanese with oral lichen planus. J Oral Pathol. 1986 Nov; 15(10): 529–33.10.1111/j.1600-0714.1986.tb00571.x
- 46. Колевски П. ХЛА–регија и болестите. Студентски збор, Скопје, 1987; 137–145.
- 47. Simon M Jr, Djawari D, Schönberger A. HLA antigens associated with lichen planus. Clin Exp Dermatol. 1984 Jul; 9(4): 435.10.1111/j.1365-2230.1984.tb00833.x
- 48. Abreu Velez AM, Howard MS, Pereyo N. Palmar and plantar lichen planus: a case report and review of the literature. An Bras Dermatol. 2015 May–Jun; 90(3 Suppl 1): 175–7. doi: 10.1590/abd1806–4841.20153034. Review.10.1590/abd1806-4841.20153034
- 49. Ognjenović M, Karelović D, Cindro VV, Tadin I. Oral lichen planus and HLA. A. Coll Antropol 1998; 22 Suppl: 89–92.
- 50. Ognjenović M, Karelović D, Mikelić M, Tadin I, Vrebalov–Cindro V. Oral lichen planus and HLA. B. Coll Antropol 1998; 22 Suppl: 93–96.
- 51. Ognjenović M, Karelović D, Cekić–Arambasin A, Tadin I, Vrebalov–Cindro V. Oral lichen planus and HLA DR. Coll Antropol 1998; 22 Suppl: 97–101.
- 52. La Nasa G, Cottoni F, Mulargia M, Carcassi C, Vacca A, Pizzati A, et al. HLA antigen distribution in different clinical subgroups demonstrates genetic heterogeneity in lichen planus. Br J Dermatol 1995; 132: 897–900.10.1111/j.1365-2133.1995.tb16945.x
- 53. Ochoa BE, King LE, Price VH. Lichen planopilaris: annual incidence in four hair referral centers in the United States. J Am Acad Dermatol 2008; 58: 352–353.10.1016/j.jaad.2007.11.007
- 54. Cevasco NC, Bergfeld WF, Remzi BK, de Knott HR. A case–series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol 2007; 57: 47–53.10.1016/j.jaad.2007.01.011
- 55. Setterfield JF, Neill S, Shirlaw PJ, Theron J, Vaughan R, Escudier M, et al. The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1*0201 allele. J Am Acad Dermatol 2006; 55: 98–113.10.1016/j.jaad.2005.12.006
- 56. Roitberg–Tambur A, Friedmann A, Korn S, Markitziu A, Pisanti S, Safirman C, et al. Sero-logic and molecular analysis of the HLA system in Israeli Jewish patients with oral erosive lichen planus. Tissue Antigens 1994; 43: 219–223.10.1111/j.1399-0039.1994.tb02328.x
- 57. White AG, Rostom AI. HLA antigens in Arabs with lichen planus. Clin Exp Dermatol 1994; 19: 236–237.10.1111/j.1365-2230.1994.tb01174.x
- 58. Porter K, Klouda P, Scully C, Bidwell J, Porter S. Class I and II HLA antigens in British patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1993; 75: 176–180.10.1016/0030-4220(93)90090-Q
- 59. Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007; 117: 2019–2027.10.1172/JCI31942193457417671634
- 60. Megiorni F, Pizzuti A, Mora B, Rizzuti A, Garelli V, Maxia C, et al. Genetic association of HLA– DQB1 and HLA–DRB1 polymorphisms with alopecia areata in the Italian population. Br J Dermatol 2011; 165: 823–827.10.1111/j.1365-2133.2011.10466.x21692766
- 61. Pavlovsky L, Israeli M, Sagy E, Berg AL, David M, Shemer A, Klein T, Hodak E. Lichen planopilaris is associated with HLA DRB1*11 and DQB1*03 alleles. Acta Derm Venereol. 2015 Feb; 95(2): 177–80. doi: 10.2340/00015555–1884.10.2340/00015555-188424806356
- 62. Akbar AN Timms A, Janossy G.Cellular events during memory T–cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis. Immunology. 1989 Feb; 66(2): 213–8.
- 63. Telagi N, Ahmed Mujib BR, Kulkarni PG2, Naik R.The master switch: Comparative study of mast cell in oral epithelial dysplasia, oral submucousfibrosis and oral squamous cells carcinoma and their association with inflammation and angio-genesis. J Oral Maxillofac Pathol. 2015 Jan–Apr; 19(1): 25–9. doi: 10.4103/0973-029X.157196.10.4103/0973-029X.157196445166126097302
- 64. Akbar AN Timms A, Janossy G.Cellular events during memory T–cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis. Immunology. 1989 Feb; 66(2): 213–8.